GILD
Gilead Sciences, Inc.
NASDAQ · USHealthcareDrug Manufacturers - General
$133.21-0.80%
Price as of Jul 20, 2026
GILD valuation
Gilead Sciences, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 14.44x
- P/E 2026E
- 15.39x
- P/E 2027E
- 13.86x
- P/E 2028E
- 12.69x
- P/S forward
- 5.36x
Trailing multiples
- P/E TTM
- 17.95x
- PEG TTM
- 0.74x
- Price / book
- 7.03x
- Price / sales
- 5.56x
- Price / cash flow
- 15.31x
Enterprise value
- Enterprise value
- $177.7B
- EV / sales
- 5.98x
- EV / EBITDA
- 12.67x
- EV / EBIT
- 15.62x
- Market cap
- $165.4B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.